JAT has partnered up with Sinopharm.
Sinopharm is the largest Chinese medical and healthcare group directly managed by the State-owned Assets Supervision and Administration Commission of the State Council (SASAC). It ranks 194thin Fortune’s 2018 Global 500 and is the sixth biggest pharmaceutical company on the list with annual revenue in 2017 of US$51.8 billion.
JAT is target 0.15 ?, page-539
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add JAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.020(4.44%) |
Mkt cap ! $58.28M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 42.5¢ | $31.64K | 73.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 47262 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 29500 | 1 |
View Market Depth
| Last trade - 14.31pm 22/11/2024 (20 minute delay) ? |
| JAT (ASX) Chart |
